Pacific Biosciences Of California Net Profit Margin 2010-2024 | PACB
Pacific Biosciences Of California net profit margin from 2010 to 2024. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Pacific Biosciences Of California Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2024-06-30 | $0.19B | $-0.40B | -211.64% |
| 2024-03-31 | $0.20B | $-0.30B | -147.76% |
| 2023-12-31 | $0.20B | $-0.31B | -152.74% |
| 2023-09-30 | $0.17B | $-0.31B | -181.76% |
| 2023-06-30 | $0.15B | $-0.32B | -218.49% |
| 2023-03-31 | $0.13B | $-0.32B | -240.60% |
| 2022-12-31 | $0.13B | $-0.31B | -246.46% |
| 2022-09-30 | $0.14B | $-0.30B | -219.12% |
| 2022-06-30 | $0.14B | $-0.20B | -146.76% |
| 2022-03-31 | $0.14B | $-0.17B | -128.89% |
| 2021-12-31 | $0.13B | $-0.18B | -137.40% |
| 2021-09-30 | $0.12B | $-0.04B | -29.51% |
| 2021-06-30 | $0.11B | $-0.08B | -72.64% |
| 2021-03-31 | $0.09B | $-0.06B | -64.13% |
| 2020-12-31 | $0.08B | $0.03B | 36.71% |
| 2020-09-30 | $0.08B | $-0.05B | -57.50% |
| 2020-06-30 | $0.08B | $-0.05B | -61.45% |
| 2020-03-31 | $0.09B | $-0.05B | -58.24% |
| 2019-12-31 | $0.09B | $-0.08B | -92.31% |
| 2019-09-30 | $0.08B | $-0.12B | -138.55% |
| 2019-06-30 | $0.08B | $-0.11B | -140.51% |
| 2019-03-31 | $0.08B | $-0.11B | -143.42% |
| 2018-12-31 | $0.08B | $-0.10B | -130.38% |
| 2018-09-30 | $0.08B | $-0.09B | -110.71% |
| 2018-06-30 | $0.09B | $-0.09B | -100.00% |
| 2018-03-31 | $0.09B | $-0.09B | -105.68% |
| 2017-12-31 | $0.09B | $-0.09B | -98.94% |
| 2017-09-30 | $0.10B | $-0.09B | -95.79% |
| 2017-06-30 | $0.10B | $-0.09B | -89.58% |
| 2017-03-31 | $0.10B | $-0.08B | -80.41% |
| 2016-12-31 | $0.09B | $-0.07B | -80.22% |
| 2016-09-30 | $0.10B | $-0.06B | -54.46% |
| 2016-06-30 | $0.09B | $-0.04B | -40.00% |
| 2016-03-31 | $0.09B | $-0.03B | -31.91% |
| 2015-12-31 | $0.09B | $-0.03B | -33.33% |
| 2015-09-30 | $0.07B | $-0.05B | -66.22% |
| 2015-06-30 | $0.08B | $-0.06B | -74.07% |
| 2015-03-31 | $0.07B | $-0.07B | -100.00% |
| 2014-12-31 | $0.06B | $-0.07B | -108.20% |
| 2014-09-30 | $0.05B | $-0.06B | -120.75% |
| 2014-06-30 | $0.04B | $-0.08B | -192.31% |
| 2014-03-31 | $0.03B | $-0.08B | -223.53% |
| 2013-12-31 | $0.03B | $-0.08B | -278.57% |
| 2013-09-30 | $0.03B | $-0.08B | -332.00% |
| 2013-06-30 | $0.02B | $-0.09B | -409.52% |
| 2013-03-31 | $0.02B | $-0.09B | -400.00% |
| 2012-12-31 | $0.03B | $-0.10B | -365.38% |
| 2012-09-30 | $0.03B | $-0.10B | -300.00% |
| 2012-06-30 | $0.04B | $-0.10B | -255.00% |
| 2012-03-31 | $0.04B | $-0.10B | -231.82% |
| 2011-12-31 | $0.03B | $-0.11B | -320.59% |
| 2011-09-30 | $0.02B | $-0.12B | -554.55% |
| 2011-06-30 | $0.01B | $-0.13B | -1218.18% |
| 2011-03-31 | $0.00B | $-0.15B | -14500.00% |
| 2010-12-31 | $0.00B | $-0.14B | -7000.00% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.722B | $0.201B |
| Pacific Biosciences of California Inc., popularly known as PacBio, develops, manufactures and markets sequencing systems, which help in studying synthesis, composition, structure and regulation of deoxyribonucleic acid, popularly known as DNA. PacBio's products are based on Single Molecule, Real-Time (SMRT) technology. SMRT generates long reads that help in assembling a whole human genome from scratch, without using an existing reference genome as a template. This process is known as de novo assembly. To observe DNA replication process smoothly, PacBio offers the SMRT Cell, Phospholinked nucleotides and The PacBio RS II System. The PacBio RS II System includes the PacBio RS II instrument, consumables and software. PacBio launched its new Sequel system based on SMRT technology. PacBio deferred the gain from the Reverse Termination Fee from Illumina until the date when the associated contingency was resolved. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $214.078B | 26.12 |
| Intuitive Surgical (ISRG) | United States | $183.628B | 96.01 |
| Alcon (ALC) | Switzerland | $45.117B | 31.76 |
| IQVIA Holdings (IQV) | United States | $40.157B | 22.12 |
| Edwards Lifesciences (EW) | United States | $39.608B | 24.62 |
| IDEXX Laboratories (IDXX) | United States | $34.672B | 40.83 |
| DexCom (DXCM) | United States | $26.799B | 40.36 |
| Waters (WAT) | United States | $22.960B | 33.95 |
| STERIS (STE) | Ireland | $22.437B | 25.85 |
| SONOVA HOLDING (SONVY) | Switzerland | $21.922B | 0.00 |
| Hologic (HOLX) | United States | $18.696B | 19.73 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $12.376B | 12.70 |
| Sysmex ADR (SSMXY) | Japan | $11.851B | 37.16 |
| Globus Medical (GMED) | United States | $11.200B | 28.52 |
| Teleflex (TFX) | United States | $9.378B | 14.96 |
| Penumbra (PEN) | United States | $8.969B | 87.86 |
| Masimo (MASI) | United States | $8.917B | 43.43 |
| Glaukos (GKOS) | United States | $7.755B | 0.00 |
| PROCEPT BioRobotics (PRCT) | United States | $5.126B | 0.00 |
| Integer Holdings (ITGR) | United States | $4.542B | 25.75 |
| Inari Medical (NARI) | United States | $3.119B | 0.00 |
| TransMedics (TMDX) | United States | $2.898B | 91.86 |
| LivaNova (LIVN) | United Kingdom | $2.829B | 16.33 |
| Veracyte (VCYT) | United States | $2.811B | 85.09 |
| Nihon Kohden (NHNKY) | Japan | $2.519B | 15.68 |
| Tandem Diabetes Care (TNDM) | United States | $2.242B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $2.227B | 18.14 |
| Integra LifeSciences Holdings (IART) | United States | $2.060B | 10.77 |
| RxSight (RXST) | United States | $2.024B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $1.257B | 0.00 |
| Artivion (AORT) | United States | $1.233B | 113.23 |
| Pulse Biosciences (PLSE) | United States | $1.110B | 0.00 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.963B | 16.37 |
| OrthoPediatrics (KIDS) | United States | $0.749B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.726B | 18.33 |
| IRadimed (IRMD) | United States | $0.712B | 38.49 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.702B | 0.00 |
| AxoGen (AXGN) | United States | $0.672B | 0.00 |
| SiBone (SIBN) | United States | $0.669B | 0.00 |
| Paragon 28 (FNA) | United States | $0.605B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.485B | 0.00 |
| CVRx (CVRX) | United States | $0.374B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.369B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.351B | 18.99 |
| Delcath Systems (DCTH) | United States | $0.304B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.301B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.291B | 19.57 |
| Sight Sciences (SGHT) | United States | $0.257B | 0.00 |
| NeuroPace (NPCE) | United States | $0.228B | 0.00 |
| Inogen (INGN) | United States | $0.227B | 0.00 |
| Nevro (NVRO) | United States | $0.216B | 0.00 |
| Accuray (ARAY) | United States | $0.204B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.186B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| 908 Devices (MASS) | United States | $0.136B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.129B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.116B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.110B | 16.32 |
| EDAP TMS S.A (EDAP) | France | $0.105B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.087B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.077B | 0.00 |
| Hyperfine (HYPR) | United States | $0.070B | 0.00 |
| LENSAR (LNSR) | United States | $0.068B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.068B | 0.00 |
| InspireMD (NSPR) | Israel | $0.061B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.060B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.051B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.049B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.047B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.046B | 0.00 |
| Envoy Medical (COCH) | United States | $0.038B | 0.00 |
| Neuronetics (STIM) | United States | $0.036B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.036B | 0.00 |
| DarioHealth (DRIO) | United States | $0.030B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| Spectral AI (MDAI) | United States | $0.028B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.028B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.020B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.019B | 0.00 | |
| NexGel (NXGL) | United States | $0.018B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.016B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.016B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.015B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.014B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.012B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.012B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.011B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.007B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |